RetinalGenix Technologies (RTGN) Invested Capital (2020 - 2026)

RetinalGenix Technologies has disclosed Invested Capital across 7 years of filings, most recently posting -$2.6 million for Q1 2026.

• Invested Capital for Q1 2026 came in at -$2.6 million, down 58.01% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.6 million (down 58.01% YoY), and the FY2025 annual result was -$2.3 million, down 59.42% from the prior year.
• Invested Capital came in at -$2.6 million for Q1 2026 at RetinalGenix Technologies, down from -$2.3 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of -$602175.0 in Q2 2022 to a low of -$2.6 million in Q1 2026.
• The 5-year median for Invested Capital is -$1.5 million (2024), against an average of -$1.5 million.
• Across the five-year window, Invested Capital slumped 1584.78% in 2022 and dropped 1.21% in 2024, its largest moves.
• RetinalGenix Technologies' Invested Capital stood at -$1.0 million in 2022, then slumped by 33.0% to -$1.4 million in 2023, then declined by 4.2% to -$1.4 million in 2024, then tumbled by 59.42% to -$2.3 million in 2025, then slipped by 13.51% to -$2.6 million in 2026.
• The last three Invested Capital figures came in at -$2.6 million (Q1 2026), -$2.3 million (Q4 2025), and -$2.1 million (Q3 2025), per Business Quant data.